Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
BioXcel Therapeutics began voluntary Chapter 11 proceedings and entered an asset sale agreement with Teva Pharmaceuticals International GmbH, with Teva set as stalking horse bidder in a court-supervised auction.
BioXcel Therapeutics filed for Chapter 11 bankruptcy and shares are trading lower.
BioXcel Therapeutics filed for Chapter 11 bankruptcy and estimated liabilities up to $500 million versus assets as low as $10 million.